In a patient with neurogenic shock, you want to replace fluids with IV fluids to correct the cause of shock.

Choice A rationale Fluid replacement is often necessary to manage the relative hypovolemia caused by massive vasodilation in neurogenic shock, but it does not correct the underlying cause. The cause is usually a spinal cord injury at T6 or above, leading to a loss of sympathetic tone. Treatment focuses on stabilizing the spine and using vasopressors to restore vascular tone. Simply giving fluids will not fix the autonomic nervous system dysfunction that initiated the shock state. Choice B rationale Neurogenic shock is characterized by hypotension and bradycardia due to the loss of sympathetic nervous system signals. While intravenous fluids are used to fill the dilated vascular bed, they are a supportive measure rather than a curative one. The cause of shock is the disruption of the neural pathways, which requires spinal stabilization and often pharmacological support like norepinephrine or phenylephrine. Fluids alone are insufficient to reverse the neurogenic etiology and must be used cautiously. Choice C rationale Neurogenic shock typically presents with profound hypotension, not hypertension. The loss of sympathetic vasoconstrictor tone results in widespread peripheral vasodilation, leading to a drop in systemic vascular resistance. Therefore, the premise of giving fluids only if the patient is hypertensive is physiologically incorrect in this context. If a patient were hypertensive, they would not be in a classic neurogenic shock state, and fluid boluses could potentially lead to fluid overload and pulmonary edema. Choice D rationale Neurogenic shock is unique among shock types because it often presents with bradycardia rather than a high heart rate. This occurs because the parasympathetic nervous system remains unopposed due to the loss of sympathetic input. Therefore, waiting for a high heart rate to initiate fluid therapy would be inappropriate, as the heart rate is typically low or normal. Fluids are used to address the hypotension resulting from the expanded vascular space, regardless of the bradycardic state.